Mark Hazeltine - May 17, 2021 Form 4 Insider Report for EXAGEN INC. (XGN)

Role: Chief Operating Officer
Signature: /s/ Kamal Adawi, as attorney-in-fact
Stock symbol: XGN
Transactions as of: May 17, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/17/2021, 08:06 PM
Next filing: Feb 8, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XGN	Common Stock	Options Exercise	$503	+1.93K	+5.16%	$0.26^*	39.4K	May 17, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XGN	Stock Option(right to buy)	Options Exercise	-$503	-1.93K	-64.57%	$0.26^*	1.06K	May 17, 2021	Common Stock	3K	$0.26	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is exercisable as it vests. 25% of the shares subject to the option vested on October 5, 2019, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.